Related Experiment Video
Updated: May 3, 2026
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Systemic delivery of small RNA using lipid nanoparticles
1Department of Medical Biochemistry, University of Shizuoka School of Pharmaceutical Sciences.
RNA interference (RNAi) therapies offer potent disease treatment. Developing effective delivery systems, particularly lipid nanoparticles, is crucial for systemic administration of RNAi therapeutics like small interfering RNA and microRNA.
Area of Science:
- Biotechnology and Pharmaceutical Sciences
- Molecular Biology and Genetics
Background:
- Gene silencing via RNA interference (RNAi) shows promise for treating various diseases due to its efficacy, specificity, and adaptability.
- Clinical application of RNAi effectors, including small interfering RNA (siRNA) and microRNA (miRNA), necessitates advanced delivery systems for effective systemic administration.
Purpose of the Study:
- To review recent advancements in systemic delivery strategies for RNAi therapeutics.
- To explore the critical design considerations for lipid nanoparticles serving as vectors for small RNA molecules.
Main Methods:
- Review of current research on chemical modifications of small RNAs.
- Analysis of encapsulation techniques for small RNAs within lipid nanoparticles.
- Evaluation of lipid nanoparticle formulations for systemic RNAi delivery.
Main Results:
- Chemical modification and lipid nanoparticle encapsulation are identified as key strategies for enhancing systemic delivery of RNAi agents.
- These approaches facilitate targeted delivery, overcoming a major hurdle in clinical RNAi therapy.
Conclusions:
- Lipid nanoparticles represent a promising platform for the systemic delivery of RNAi therapeutics.
- Optimized design of lipid nanoparticles is essential for maximizing the therapeutic potential of small interfering RNA and microRNA.
More Related Videos
10:33Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
Related Concept Videos
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
02:15Experimental RNAi
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:30Small interfering RNAs (siRNA)